美股市场个股详情

ARTV Artiva Biotherapeutics

添加自选

10.960
+0.480+4.58%

收盘价 12/24 13:00 (美东)

2.66亿总市值-4.34市盈率TTM

关于Artiva Biotherapeutics公司

Artiva Biotherapeutics Inc 是一家生物制药公司。该公司致力于推进现成的、同种异体NK细胞疗法的管道，用于治疗血液恶性肿瘤或实体肿瘤。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。

公司介绍

公司代码ARTV

公司名称Artiva Biotherapeutics

上市日期2024/07/19

发行价格12.00

成立日期2019

CEODr. Fred Aslan, M.D.

所属市场纳斯达克

员工数量81

年结日12-31

公司地址5505 Morehouse Drive,Suite 100

城市San Diego

省份加利福尼亚州

国家美国

邮编92121

电话1-858-267-4467

网址http://www.artivabio.com

董事高管

姓名
职务
年薪

Dr. Fred Aslan, M.D.
President, Chief Executive Officer and Director
110.78万

Neha Krishnamohan
Executive Vice President, Corporate Development, Chief Financial Officer and Principal Accounting Officer
--

Thorsten Graef, M.D.,PhD
Chief Medical Officer
--

Christopher Horan
Chief Technical Operations Officer
72.69万

Jennifer Kinsbruner Bush
Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer
72.58万

Dr. Heather Raymon, PhD
Senior Vice President, Research and Early Development
--

Dr. Brian Daniels,M.D.
Chairman of the Board
--

Yong-Jun Huh
Director
--

James Jong-eun Park
Director
--

Dr. Diego Miralles, M.D.
Director
--

Dr. Alison Moore, PhD
Director
--

Dr. Yvonne Yamanaka, PhD
Independent Director
--

Elizabeth L. Hougen
Independent Director
--

Dr. Laura Stoppel, PhD
Independent Director
--

Dr. Laura Bessen, M.D.
Independent Director
--

美股市场投资机会

代码迷你走势涨跌幅

Bitdeer Technologies

Digihost Technology

Argo Blockchain

解锁榜首股票

相关主题投资

次新股